Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOTICGeneric

OTOBIOTIC

HYDROCORTISONE; POLYMYXIN B SULFATE

Standard Dose
5MG/ML;EQ 10,000 UNITS BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview OTOBIOTIC is listed in Drugs@FDA under application 062302 (ANDA).

Marketing status: Discontinued Active ingredient HYDROCORTISONE; POLYMYXIN B SULFATE Form and strength SOLUTION/DROPS;OTIC - 5MG/ML;EQ 10,000 UNITS BASE/ML Sponsor SCHERING Submission history Latest submission status date: 2000-02-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview OTOBIOTIC is listed in Drugs@FDA under application 062302 (ANDA). Marketing status: Discontinued Active ingredient HYDROCORTISONE; POLYMYXIN B SULFATE Form and strength SOLUTION/DROPS;OTIC - 5MG/ML;EQ 10,000 UNITS BASE/ML Sponsor SCHERING Submission history Latest submission status date: 2000-02-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
OTOBIOTIC (HYDROCORTISONE; POLYMYXIN B SULFATE) | Drug Monograph | MedicHelpline